Delivery Order SPE2DB24D3014-SPE2DB25FKTUY
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, with a ceiling value of $1,102.28 and a completion date of June 6, 2025. This contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,886.78 and a completion date of July 8, 2025. The contract is a Firm Fixed Price delivery order, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, and has a firm fixed price ceiling value of $1,136.10. The contract is not set aside and has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,877.07 and a completion date of July 8, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price of $12,610.10 and a completion date of July 9, 2025. This delivery order contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a prescription medication, with a ceiling value of $3,472.26 and a completion date of January 23, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,302.45 and a period of performance through May 14, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a ceiling value of $1,665.16 and a performance period ending on May 22, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,967.70 and a period of performance through July 10, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a prescription medication. The contract has a ceiling value of $4,238.40 and is a firm fixed-price delivery order with a completion date of July 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTUYDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML medication, with a ceiling value of $3,552.76 and a completion date of June 26, 2025. The contract is a firm-fixed-price delivery order, and it is not set aside for any specific business categories. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/25/25 |